Date:8/9/2012

ket, India, Revenue ($m), 2003-2010 93Figure 72: Fetal Monitors Market, India, Revenue ($m), 2010-2017 94Figure 73: Antepartum Monitors Market, Brazil, Revenue ($m), 2003-2010 95Figure 74: Antepartum Monitors Market, Brazil, Revenue ($m), 2010-2017 96Figure 75: Fetal Monitors Market, China, Company Share (%), 2010 97Figure 76: Fetal Monitors Market, India, Company Share (%), 2010 98Figure 77: Antepartum Monitors Market, Brazil, Company Share (%), 2010 99Figure 78: Patient Monitoring Equipment Market, China, Competitive Assessment, 2011 101Figure 79: Patient Monitoring Equipment Market, India, Competitive Assessment, 2011 102Figure 80: Patient Monitoring Equipment Market, Brazil, Competitive Assessment, 2011 103

Companies Mentioned

Philips Healthcare Omron Healthcare GE Healthcare Mindray Medical International Limited Nihon Kohden Corporation Draegerwerk AG & Co. KGaA Larsen & Toubro Medical Equipment & SystemsCovidien plc Microlife Corporation Sunray Medical Apparatus Co., Ltd. BIOTRONIK 3M Health Care (Subsidiary of 3M Company)

To order this report:Medical Equipment and Supply Industry: Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth

More  

Market Research Report

Check our  

Industry Analysis and Insights

<
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way